FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/13/2026
Autolus Therapeutics (NASDAQ: AUTL) reported Q3 EPS of ($0.26), $0.01 worse than the analyst estimate of ($0.25).
For earnings history and earnings-related data on Autolus Therapeutics (AUTL) click here.
... More
